Badr Ait Hammou

Single-cell transcriptomic technology has now matured, allowing quantification of mRNA transcripts corres… (see more)ponding to tens of thousands of genes within a cell. However, still only a small fraction of these mRNA is captured and measured by today’s single-cell assays. There are likely hundreds of thousands of mRNA copies present within a typical human cell, yet these assays omit a majority of the transcripts that are actually present. This introduces technical noise, especially non-biological variability and excessive sparsity, which frustrates downstream analysis and potentially skews biological conclusions. To overcome these challenges, we here develop HyperCell, a probabilistic deep learning approach that explicitly models this undersampling to produce estimates of each cell’s original gene transcript abundances across the whole transcriptome. We demonstrate that our framework offers benefits in various mRNA modeling settings, by i) correctly differentiating between spurious sampling-induced and real biological zeros, outperforming existing approaches, ii) estimating the total mRNA content of cells across states to reduce contamination due to background transcripts, iii) reducing contamination due to background transcripts, and iv) helping to counteract biases that may appear during typical differential gene expression analyses using widespread normalization approaches. Our approach to correcting for the technical noise introduced by the single-cell experimental process brings us closer to studying biology, starting from the true transcriptome of cells.

Historically, Alzheimer’s disease (AD) and Parkinson’s disease (PD) have been investigated as two distinct disorders of the brain. Howev… (see more)er, a few similarities in neuropathology and clinical symptoms have been documented over the years. Traditional single gene-centric genetic studies, including GWAS and differential gene expression analyses, have struggled to unravel the molecular links between AD and PD. To address this, we tailor a pattern-learning framework to analyze synchronous gene co-expression at sub-cell-type resolution. Utilizing recently published single-nucleus AD (70,634 nuclei) and PD (340,902 nuclei) datasets from postmortem human brains, we systematically extract and juxtapose disease-critical gene modules. Our findings reveal extensive molecular similarities between AD and PD gene cliques. In neurons, disrupted cytoskeletal dynamics and mitochondrial stress highlight convergence in key processes; glial modules share roles in T-cell activation, myelin synthesis, and synapse pruning. This multi-module sub-cell-type approach offers insights into the molecular basis of shared neuropathology in AD and PD.

Historically, Alzheimer’s disease (AD) and Parkinson’s disease (PD) have been investigated as two distinct disorders of the brain. Howev… (see more)er, a few similarities in neuropathology and clinical symptoms have been documented over the years. Traditional single gene-centric genetic studies, including GWAS and differential gene expression analyses, have struggled to unravel the molecular links between AD and PD. To address this, we tailor a pattern-learning framework to analyze synchronous gene co-expression at sub-cell-type resolution. Utilizing recently published single-nucleus AD (70,634 nuclei) and PD (340,902 nuclei) datasets from postmortem human brains, we systematically extract and juxtapose disease-critical gene modules. Our findings reveal extensive molecular similarities between AD and PD gene cliques. In neurons, disrupted cytoskeletal dynamics and mitochondrial stress highlight convergence in key processes; glial modules share roles in T-cell activation, myelin synthesis, and synapse pruning. This multi-module sub-cell-type approach offers insights into the molecular basis of shared neuropathology in AD and PD.